<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="ro">
	<id>https://wiki.tradeville.ro/index.php?action=history&amp;feed=atom&amp;title=SAGE_THERAPEUTICS_INC</id>
	<title>SAGE THERAPEUTICS INC - Revizia istoricului</title>
	<link rel="self" type="application/atom+xml" href="https://wiki.tradeville.ro/index.php?action=history&amp;feed=atom&amp;title=SAGE_THERAPEUTICS_INC"/>
	<link rel="alternate" type="text/html" href="https://wiki.tradeville.ro/index.php?title=SAGE_THERAPEUTICS_INC&amp;action=history"/>
	<updated>2026-04-03T19:41:45Z</updated>
	<subtitle>Istoricul versiunilor pentru această pagină din wiki</subtitle>
	<generator>MediaWiki 1.39.2</generator>
	<entry>
		<id>https://wiki.tradeville.ro/index.php?title=SAGE_THERAPEUTICS_INC&amp;diff=439397&amp;oldid=prev</id>
		<title>Admin: Pagină nouă: Pagina dedicata companiei SAGE THERAPEUTICS INC listata cu simbolul US.SAGE  ==Descriere companie== SAGE Therapeutics, Inc. (https://www.sagerx.com/) is a biopharmaceutical company that is focused on developing and commercializing medicines with debilitating disorders of the brain. The Company's product, ZULRESSO (brexanolone) CIV injection, is for the treatment of postpartum depression (PPD), in adults. The Company's products also include ZULRESSO (Brexanolone) CIV Injection...</title>
		<link rel="alternate" type="text/html" href="https://wiki.tradeville.ro/index.php?title=SAGE_THERAPEUTICS_INC&amp;diff=439397&amp;oldid=prev"/>
		<updated>2024-09-18T18:26:55Z</updated>

		<summary type="html">&lt;p&gt;Pagină nouă: Pagina dedicata companiei SAGE THERAPEUTICS INC listata cu simbolul US.SAGE  ==Descriere companie== SAGE Therapeutics, Inc. (https://www.sagerx.com/) is a biopharmaceutical company that is focused on developing and commercializing medicines with debilitating disorders of the brain. The Company&amp;#039;s product, ZULRESSO (brexanolone) CIV injection, is for the treatment of postpartum depression (PPD), in adults. The Company&amp;#039;s products also include ZULRESSO (Brexanolone) CIV Injection...&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Pagină nouă&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Pagina dedicata companiei SAGE THERAPEUTICS INC listata cu simbolul US.SAGE&lt;br /&gt;
&lt;br /&gt;
==Descriere companie==&lt;br /&gt;
SAGE Therapeutics, Inc. (https://www.sagerx.com/) is a biopharmaceutical company that is focused on developing and commercializing medicines with debilitating disorders of the brain. The Company's product, ZULRESSO (brexanolone) CIV injection, is for the treatment of postpartum depression (PPD), in adults. The Company's products also include ZULRESSO (Brexanolone) CIV Injection, Zuranolone (SAGE-217), SAGE-324 and SAGE-718. Its next advanced product candidate is SAGE-217, is an oral compound that is in Phase III clinical development in PPD and depressive disorder (MDD). Zuranolone is a neuroactive steroid that, like brexanolone, is a positive allosteric modulator of GABAA receptors, targeting both synaptic and extrasynaptic GABAA receptors. SAGE-324 is a GABAA receptor positive allosteric modulator intended for chronic oral dosing and conducting a placebo-controlled Phase II clinical trial evaluating the safety and efficacy of SAGE-324 in the treatment of essential tremor.&lt;br /&gt;
&lt;br /&gt;
==Grafic actiuni companie==&lt;br /&gt;
&amp;lt;iframe key=&amp;quot;tradeville&amp;quot; path=&amp;quot;graficSimbol/US.SAGE&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Ultimele stiri despre SAGE THERAPEUTICS INC (US.SAGE)==&lt;br /&gt;
&amp;lt;dynamicpagelist&amp;gt;&lt;br /&gt;
category=US.SAGE&lt;br /&gt;
count=10&lt;br /&gt;
order=descending&lt;br /&gt;
addfirstcategorydate=false&lt;br /&gt;
&amp;lt;/dynamicpagelist&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Categorie:US.SAGE]][[Categorie:Stiri despre companii]]&lt;/div&gt;</summary>
		<author><name>Admin</name></author>
	</entry>
</feed>